yo-pro-1 and Chronic-Pain

yo-pro-1 has been researched along with Chronic-Pain* in 2 studies

Other Studies

2 other study(ies) available for yo-pro-1 and Chronic-Pain

ArticleYear
Pulsed radiofrequency for chronic pain: In vitro evidence of an electroporation mediated calcium uptake.
    Bioelectrochemistry (Amsterdam, Netherlands), 2020, Volume: 136

    Pulsed radiofrequency (PRF) treatments for chronic pain consist in the delivery of a train of sinusoidal electric bursts to the targeted nerve. Despite numerous clinical evidence of its efficiency, the mechanism of action of PRF remains unclear. Since most of the reported biological effects of PRF can be initiated by a calcium influx into the neurons, we hypothesized that PRF may induce a mild electroporation effect causing a calcium uptake. To test this hypothesis, HEK-293 cells were exposed to PRF bursts and cytosolic calcium and Yo-Pro-1 uptake were monitored. After a single burst, calcium peaks were observed for electric fields above 480 V/cm while the uptake of Yo-pro-1 was insignificant. After a train of 120 bursts, the electric fields required to induce a calcium and Yo-pro-1 uptake decreased to 330 V/cm and 880 V/cm respectively. Calcium peaks were not detected when cells were treated in calcium free media. The temperature increase during the treatments was lower than 5 °C in all cases. Finally, the cell response for different burst frequencies and extracellular media conductivities correlated with the induced transmembrane voltage calculated with a numerical model. Our results support the hypothesis of an electroporation mediated calcium influx.

    Topics: Benzoxazoles; Calcium; Chronic Pain; Cytosol; Electroporation; HEK293 Cells; Humans; In Vitro Techniques; Membrane Potentials; Neurons; Pulsed Radiofrequency Treatment; Quinolinium Compounds; Temperature

2020
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.
    Nature medicine, 2012, Mar-25, Volume: 18, Issue:4

    Chronic pain is highly variable between individuals, as is the response to analgesics. Although much of the variability in chronic pain and analgesic response is heritable, an understanding of the genetic determinants underlying this variability is rudimentary. Here we show that variation within the coding sequence of the gene encoding the P2X7 receptor (P2X7R) affects chronic pain sensitivity in both mice and humans. P2X7Rs, which are members of the family of ionotropic ATP-gated receptors, have two distinct modes of function: they can function through their intrinsic cationic channel or by forming nonselective pores that are permeable to molecules with a mass of up to 900 Da. Using genome-wide linkage analyses, we discovered an association between nerve-injury-induced pain behavior (mechanical allodynia) and the P451L mutation of the mouse P2rx7 gene, such that mice in which P2X7Rs have impaired pore formation as a result of this mutation showed less allodynia than mice with the pore-forming P2rx7 allele. Administration of a peptide corresponding to the P2X7R C-terminal domain, which blocked pore formation but not cation channel activity, selectively reduced nerve injury and inflammatory allodynia only in mice with the pore-forming P2rx7 allele. Moreover, in two independent human chronic pain cohorts, a cohort with pain after mastectomy and a cohort with osteoarthritis, we observed a genetic association between lower pain intensity and the hypofunctional His270 (rs7958311) allele of P2RX7. Our findings suggest that selectively targeting P2X7R pore formation may be a new strategy for individualizing the treatment of chronic pain.

    Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Calcium; Carbenoxolone; Cells, Cultured; Chronic Pain; Cohort Studies; Connexins; Disease Models, Animal; Enzyme Inhibitors; Female; Genetic Linkage; Genome-Wide Association Study; Genotype; Histidine; Humans; Hyperalgesia; Macrophages; Male; Mastectomy; Mice; Mice, Inbred Strains; Mutation; Nerve Tissue Proteins; Osteoarthritis; Pain Measurement; Pain Threshold; Peptides; Polymorphism, Single Nucleotide; Quinolinium Compounds; Receptors, Purinergic P2X7; Retrospective Studies; Species Specificity; Time Factors; Transfection

2012